Cxbladder Triage Plus
Urine molecular test combining gene-expression biomarkers with DNA variants for risk stratification in urothelial cancer evaluation.
- Developer
- Pacific Edge
- Intended use
- Risk Stratification
- Cancer scope
- Urothelial cancer
- Specimen
- Urine
- Molecular modality
- DNA mutation, RNA expression
- Current version
- Current Cxbladder Triage Plus configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.